Battery electric vehicle prices fell 18% and model choice quadrupled between 2020 and 2025

20.7.2026 06:00:00 CEST | news aktuell GmbH | Press Release

Share

New study analyzes EV purchase prices and market trends in Germany, Europe's largest car market

(Berlin) July 20, 2026 – In Europe's largest automotive market, battery electric cars became about 18 percent cheaper in real terms between 2020 and 2025, even as average prices appeared to rise as a result of a changing model mix. Meanwhile, the number of electric models available on the market has more than quadrupled.

That is the finding of a new joint study by the International Council on Clean Transportation (ICCT) and the Fraunhofer Institute for Systems and Innovation Research ISI, covering the German market as a key indicator of broader European trends. The study draws on more than 100,000 individual data points across six vehicle segments, from small to luxury cars.

“Our results show that the market for electric cars has evolved significantly in recent years. Today, these vehicles offer, on average, longer ranges and more engine power, while the actual prices of comparable models have fallen. This a clear indicator of where Europe’s automotive market is headed,” said Peter Mock, Europe Managing Director at the ICCT.

Read the full press release, including additional findings on battery prices and model availability, at https://theicct.org/pr-battery-electric-vehicle-prices-fell-18-percent-and-model-choice-quadrupled-between-2020-and-2025/

Media contact

Sophie Ehmsen (ICCT)
Communications Specialist
communications@theicct.org

Publication details

Title: Price and market trends of battery electric and internal combustion engine vehicles in Germany, 2020 to 2025

Authors:
Patrick Plötz, Steffen Link (Fraunhofer Institute for Systems and Innovation Research ISI)
Kyle Morrison, Uwe Tietge, Eyal Li, Peter Mock (International Council on Clean Transportation, ICCT)

Please use this link to cite the study: theicct.org/publication/price-and-market-trends-of-battery-electric-and-internal-combustion-engine-vehicles-in-germany-2020-2025-jul26

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Polpharma Strengthens Its Position in Central and Eastern Europe – Biofarm, the Leader of the Romanian Market, Joins the Group21.7.2026 11:00:00 CEST | Press Release

Warsaw, 21.07.2026 - Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe. With Biofarm joining the Group, Polpharma is expanding the scale of its operations, reinforcing its presence in key regional markets, and creating new opportunities to improve patients’ access to trusted medicines across the region and beyond.

Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich16.7.2026 10:32:18 CEST | Press Release

Aachen, Germany, 16 July 2026 – Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic acid therapeutics into innovative treatments that can make a meaningful difference for patients. Joining the CNATM provides Grünenthal with a valuable platform to strengthen its oligonucleotide drug discovery capabilities and connect its growing internal expertise with one of Germany’s leading academic and biotech innovation ecosystems. Over the last few years, Grünenthal has built strategic in-house capabilities to advance oligonucleotide modalities, including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA), as potential therapeutic approaches for pain and related neurological indications. One of Grünenthal’s key objectives for the collaboration

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye